P3.01-048 CBL Mutations as Potential Mediators of EGFR TKI Resistance Effectively Treated with Sitravatinib
Bazhenova, L., Neuteboom, S., Chen, I., Chao, R., Christensen, J.Volume:
12
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2017.09.1489
Date:
November, 2017
File:
PDF, 513 KB
english, 2017